» Authors » Gabor Csukly

Gabor Csukly

Explore the profile of Gabor Csukly including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 78
Citations 782
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Csukly G, Molnar H, Marosi C, Fodor Z, Farkas K
Schizophrenia (Heidelb) . 2025 Mar; 11(1):39. PMID: 40055340
In schizophrenia, deficits in social cognition, such as facial emotion identification, have a significant impact on patient's daily functioning and quality of life. We analyzed the beta event-related desynchronization (ERD)...
2.
Torok-Suri K, Nemeth K, Baradits M, Csukly G
J Imaging . 2025 Feb; 11(2). PMID: 39997562
Individual differences in attachment orientations may influence how we process emotionally significant stimuli. As one of the most important sources of emotional information are facial expressions, we examined whether there...
3.
Racz F, Farkas K, Becske M, Molnar H, Fodor Z, Mukli P, et al.
Schizophrenia (Heidelb) . 2025 Feb; 11(1):20. PMID: 39966406
Altered neural excitation/inhibition (E/I) balance has long been suspected as a potential underlying cause for clinical symptoms in schizophrenia (SZ). Recent methodological advancements linking the spectral slope (β) of neurophysiological...
4.
Vass A, Csukly G, Farkas K
Neuropsychopharmacol Hung . 2025 Jan; 26(4):218-226. PMID: 39760675
Aims: Autism spectrum disorder and schizophrenia are traditionally viewed as distinct diagnostic categories. However, evidence increasingly suggests overlapping pathological functioning at various levels, starting from brain circuitry to behaviour. Notably,...
5.
Huszar Z, Solomon A, Engh M, Koszovacz V, Terebessy T, Molnar Z, et al.
Alzheimers Res Ther . 2024 Oct; 16(1):238. PMID: 39462394
Background: Dementia preventive interventions targeting multiple modifiable risk factors are a promising approach. However, the impact of modifiable risk factors in the presence of beta-amyloid or phosphorylated-tau (p-tau) pathology is...
6.
Vass E, Gerlinger L, Egervari L, Kilencz T, Csukly G, Herman L, et al.
Acta Psychol (Amst) . 2024 Oct; 250:104520. PMID: 39405743
Schizophrenia spectrum disorder poses a complex challenge in psychiatric treatment due to its multifaceted symptomatology. Modified AVATAR therapy, an innovative virtual reality-based intervention integrating Cognitive Behavioral Therapy (CBT) techniques such...
7.
Lanyi O, Koleszar B, Wenning A, Balogh D, Engh M, Horvath A, et al.
Schizophrenia (Heidelb) . 2024 Jun; 10(1):56. PMID: 38879590
Cortical excitation-inhibition (E/I) imbalance is a potential model for the pathophysiology of schizophrenia. Previous research using transcranial magnetic stimulation (TMS) and electromyography (EMG) has suggested inhibitory deficits in schizophrenia. In...
8.
Szirmai D, Zabihi A, Koi T, Hegyi P, Wenning A, Engh M, et al.
Heliyon . 2024 Jun; 10(10):e31277. PMID: 38826755
Outcome prediction in prolonged disorders of consciousness (DOC) remains challenging. This can result in either inappropriate withdrawal of treatment or unnecessary prolongation of treatment. Electroencephalography (EEG) is a cheap, portable,...
9.
Marik A, Miklos I, Csukly G, Harsfalvi P, Novak A
Int J Colorectal Dis . 2024 May; 39(1):72. PMID: 38750150
Background And Aims: A high number of topical products are available for the treatment of hemorrhoidal symptoms. Sucralfate-based topical products constitute a new treatment alternative that act as a mechanical...
10.
Becske M, Marosi C, Molnar H, Fodor Z, Farkas K, Racz F, et al.
Sci Rep . 2024 May; 14(1):10495. PMID: 38714807
Schizophrenia is a serious and complex mental disease, known to be associated with various subtle structural and functional deviations in the brain. Recently, increased attention is given to the analysis...